The end of the COVID-19 pandemic will depend on our ability to address vaccine hesitancy, one of the top 10 threats to global health, before a vaccine is put on the market. Meeting the Challenge of Vaccination Hesitancy, a report published in June 2020 by the Sabin-Aspen Vaccine Science & Policy Group, lays out actionable steps that leaders across healthcare, research, philanthropy and technology can take to build confidence in vaccines and vaccinations.
Even before the COVID-19 pandemic, worldwide measles outbreaks in communities with low immunization rates revealed gaps in the herd
The end of the COVID-19 pandemic will depend on our ability to address vaccine hesitancy, one of the top 10 threats to global health, before a vaccine is put on the market. Meeting the Challenge of Vaccination Hesitancy, a report published in June 2020 by the Sabin-Aspen Vaccine Science & Policy Group, lays out actionable steps that leaders across healthcare, research, philanthropy and technology can take to build confidence in vaccines and vaccinations. Even before the COVID-19 pandemic, worldwide measles outbreaks in communities with low immunization rates revealed gaps in the herd
